Work

Table S6 from Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors

Year: 2023
Type: other
Abstract: Supplementary Table S6 presents multivariate analysis of pooled clinical trial data on R/R MM patients achieving stringent complete response (sCR) – variables include statin use, t11;14 status, prior lines of therapy, cytogenetic risk.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4389489586
Cites:
Cited by:
Related to: 10